Say goodbye to uneven skin tone and hello to smooth, hydrated, and rejuvenated skin
Chemotherapy agents, particularly cisplatin and other platinum based drugs, are another important consideration

Individuals with any of the following conditions should consult with their healthcare provider before use and may not be eligible for treatment: Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) Known hypersensitivity to GLP-1 or GLP-1/GIP medications or any formulation components, including additives such as vitamin B12 or cobalt Pregnancy or plans to become pregnant (therapy should be discontinued at least two months prior to planned pregnancy) Diabetic ketoacidosis (DKA) or type 1 diabetes Severe gastrointestinal disease (including gastroparesis or active inflammatory bowel disease) Severe cardiovascular disease (including unstable coronary artery disease or heart failure) Recent bariatric or gastrointestinal surgery within the past six months Active cancer currently undergoing chemotherapy or radiation treatment This list is not comprehensive

Preclinical efficacy of the novel Monocarboxylate Transporter 1 Inhibitor BAY-8002 and Associated Markers of Resistance
Dumbrava EI, Balaji K, Raghav K, Javle M, Blum-Murphy M, Sajan B, Kopetz S , Broaddus R, Routbort M, Pant S, Tsimberidou A, Subbiah V, Hong DS, Ahnert JR, Shaw K, Piha-Paul S, Meric-Bernstam F
High chronic stress creates hostile environment for peptide effectiveness regardless of perfect product application